| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | T | United States | $24.59 | $124,480,000,000.00 | Buy | 20 | N/A |
#2 | VZ | United States | $40.87 | $137,491,000,000.00 | Buy | 12 | 2000 |
#3 | SNY | France | $48.64 | $53,890,648,839.00 | Buy | 5 | N/A |
#4 | BN | Canada | $45.68 | $76,933,000,000.00 | Strong Buy | 7 | N/A |
#5 | CMCSA | United States | $27.20 | $123,311,000,000.00 | Buy | 23 | 1972 |
#6 | NU | Brazil | $16.84 | $6,360,698,000.00 | Buy | 9 | 2021 |
#7 | EPD | United States | $32.12 | $53,004,000,000.00 | Buy | 12 | 1998 |
#8 | FCX | United States | $47.41 | $26,002,000,000.00 | Strong Buy | 16 | N/A |
#9 | CSX | United States | $37.37 | $14,123,000,000.00 | Buy | 23 | N/A |
#10 | AMX | Mexico | $21.30 | $51,012,503,011.00 | Buy | 6 | 2001 |
#11 | KMI | United States | $26.73 | $16,416,000,000.00 | Buy | 13 | 2011 |
#12 | ET | United States | $16.58 | $79,757,000,000.00 | Buy | 13 | 2006 |
#13 | SLB | United States | $39.42 | $35,247,000,000.00 | Strong Buy | 16 | N/A |
#14 | WBD | United States | $29.98 | $37,863,000,000.00 | Buy | 23 | N/A |
#15 | CPNG | United States | $25.56 | $33,664,000,000.00 | Strong Buy | 6 | 2021 |
#16 | BKR | United States | $46.79 | $27,711,000,000.00 | Strong Buy | 18 | N/A |
#17 | JD | China | $29.40 | $183,136,729,092.00 | Buy | 11 | 2014 |
#18 | VALE | Brazil | $12.69 | $40,027,019,862.00 | Buy | 8 | N/A |
#19 | CMG | United States | $36.14 | $11,787,400,000.00 | Buy | 28 | 2006 |
#20 | KVUE | United States | $17.33 | $15,006,000,000.00 | Buy | 13 | 2023 |
#21 | GFI | South Africa | $43.24 | $6,555,200,000.00 | Buy | 8 | 2007 |
#22 | KDP | United States | $29.53 | $16,174,000,000.00 | Buy | 16 | 1993 |
#23 | PCG | United States | $15.17 | $24,762,000,000.00 | Buy | 10 | N/A |
#24 | CUK | United States | $25.52 | $26,230,000,000.00 | Strong Buy | 17 | 2000 |
#25 | CCL | United States | $27.66 | $26,230,000,000.00 | Strong Buy | 17 | 1987 |
#26 | KGC | Canada | $27.90 | $6,443,900,000.00 | Strong Buy | 5 | N/A |
#27 | VICI | United States | $28.66 | $3,969,078,000.00 | Buy | 15 | N/A |
#28 | MT | Luxembourg | $46.21 | $61,095,000,000.00 | Buy | 6 | 1997 |
#29 | FITB | United States | $48.19 | $8,125,000,000.00 | Buy | 16 | N/A |
#30 | TEVA | Israel | $29.77 | $16,776,000,000.00 | Strong Buy | 9 | N/A |
#31 | TME | China | $18.21 | $4,455,416,345.00 | Strong Buy | 5 | 2018 |
#32 | STM | Netherlands | $25.99 | $11,792,000,000.00 | Buy | 7 | 1994 |
#33 | HBAN | United States | $17.80 | $7,502,000,000.00 | Buy | 17 | N/A |
#34 | CNP | United States | $37.78 | $9,114,000,000.00 | Buy | 12 | N/A |
#35 | PPL | United States | $33.97 | $8,979,000,000.00 | Buy | 10 | N/A |
#36 | HAL | United States | $28.54 | $22,137,000,000.00 | Strong Buy | 16 | N/A |
#37 | FE | United States | $44.19 | $14,283,000,000.00 | Buy | 14 | N/A |
#38 | KEY | United States | $20.61 | $5,934,000,000.00 | Buy | 14 | N/A |
#39 | DVN | United States | $37.52 | $16,554,000,000.00 | Buy | 21 | N/A |
#40 | RF | United States | $27.61 | $6,945,000,000.00 | Buy | 14 | N/A |
#41 | TOST | United States | $35.28 | $5,858,000,000.00 | Buy | 22 | 2021 |
#42 | GRAB | Singapore | $5.16 | $3,228,000,000.00 | Buy | 4 | N/A |
#43 | TS | Luxembourg | $40.35 | $11,831,250,000.00 | Buy | 5 | N/A |
#44 | TECK | Canada | $43.18 | $7,526,796,802.00 | Buy | 7 | N/A |
#45 | NTNX | United States | $47.67 | $2,617,547,000.00 | Buy | 16 | 2016 |
#46 | SMCI | United States | $32.34 | $21,052,576,000.00 | Buy | 17 | 2007 |
#47 | CTRA | United States | $26.33 | $6,666,000,000.00 | Buy | 16 | 1990 |
#48 | NI | United States | $41.39 | $6,327,100,000.00 | Buy | 9 | N/A |
#49 | VIV | Brazil | $12.30 | $10,989,199,704.00 | Buy | 4 | 1998 |
#50 | AMCR | Switzerland | $8.25 | $17,401,000,000.00 | Buy | 7 | N/A |
The FinQuota filters have identified what they believe to be the "Best Blue Chip Stocks Under $50 (December 2025) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.